Daniel Getts is the founder of Myeloid Therapeutics. Myeloid Therapeutics has raised $195M in total funding. Latest round: Series A. Based in Cambridge, MA.
Daniel Getts is the Chief Executive Officer of Myeloid Therapeutics, a clinical-stage mRNA-immunotherapy company focused on developing therapies for cancer patients. The company, which recently rebranded as CREATE Medicines, aims to advance its CAR-T candidates through human trials. Myeloid Therapeutics has secured significant funding rounds, including a $73 million financing round and a $122 million round to support its clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library